US009550052B2
`
`a2) United States Patent
`US 9,550,052 B2
`(0) Patent No.:
`Jan. 24, 2017
`(45) Date of Patent:
`Ignon etal.
`
`(54)
`
`(71)
`
`(72)
`
`CONSOLE SYSTEM FOR THE TREATMENT
`OF SKIN
`
`Applicant: EDGE SYSTEMS LLC, Signal Hill,
`CA (US)
`
`Inventors: Roger Ignon, Redondo Beach, CA
`(US); Scott Mallett, Coto De Caza, CA
`(US); Abraham Solano, Corona, CA
`(US); William Cohen, Los Alamitos,
`CA (US)
`
`(73)
`
`Assignee: Edge Systems LLC, Signal Hill, CA
`(US)
`
`2017/00761;A61B 19/0248; A61B
`2019/025; A61B 2217/005; A61B
`2217/007; A61B 17/50; A61B
`2017/320004; A61B 50/10; A61B 50/13;
`A61M 35/003; A61N 5/0616
`See application file for complete search history.
`
`(56)
`
`References Cited
`U.S. PATENT DOCUMENTS
`
`2,608,032 A
`2,631,583 A
`
`8/1952 Garver
`3/1953 Lavergne
`(Continued)
`
`Subject to any disclaimer, the term ofthis
`Notice:
`(*)
`patent is extended or adjusted under 35
`DE 34 21390 Al=12/1985
`
`DE
`234 608
`4/1986
`U.S.C. 154(b) by 0 days.
`
`FOREIGN PATENT DOCUMENTS
`
`(21)
`
`Appl. No.: 14/698,673
`
`(22)
`
`Filed:
`
`Apr. 28, 2015
`
`(65)
`
`(63)
`
`Prior Publication Data
`
`US 2015/0272623 Al
`
`Oct. 1, 2015
`
`Related U.S. Application Data
`
`Continuation of application No. 13/267,554, filed on
`Oct. 6, 2011, which is a continuation of application
`(Continued)
`
`(51)
`
`Int. Cl.
`
`A6IM 35/00
`A6IB 17/54
`
`(52)
`
`USS. Cl.
`
`(2006.01)
`(2006.01)
`(Continued)
`
`(58)
`
`CPC ........ A6IM 35/003 (2013.01); A6IB 173205
`(2013.01); A61B 17/50 (2013.01);
`(Continued)
`Field of Classification Search
`CPC oo A61B 17/54; A61B 17/545; A61B
`2017/00017; A61B 2017/00199; A61B
`2017/00743; A61B 2017/00747, A61B
`
`(Continued)
`
`OTHER PUBLICATIONS
`
`Cox III et al., Decreased Splatter in Dermabrasion, Arch Facial
`Plastic Surgery, Jan.-Mar. 2000, vol. 2, pp. 23-26.
`(Continued)
`
`Primary Examiner — Ryan J Severson
`Assistant Examiner — Christian Knauss
`
`(74) Attorney, Agent, or Firm — Knobbe, Martens, Olson
`& Bear, LLP
`
`(57)
`
`ABSTRACT
`
`An apparatus for treating skin has a console with a user input
`device and a handpiece assembly. The handpiece assembly
`is configured to treat skin. A fluid line provides fluid
`communication between the console and the handpiece
`assembly. A manifold system is coupled to the console and
`controlled by the user input device. The manifold system is
`configured to hold releasably a plurality of fluid sources and
`deliver fluid from at least one ofthe plurality of fluid sources
`to the handpiece assembly.
`
`
`
`
`17 Claims, 25 Drawing Sheets
`
`Sinclair Pharmaetal.
`EUNSUNG-1017
`
`Sinclair Pharma et al.
`EUNSUNG-1017
`
`1
`
`

`

`US 9,550,052 B2
`
`Page 2
`
`PPPPPSEPEEEEEEESEPEEEEESESEPEESESEEEEEPEESPPEEPPEPSESEEEEPPPY
`
`B2
`B2
`Bl
`
`Related U.S. Application Data
`
`No. 11/392,348,filed on Mar. 29, 2006, now Pat. No.
`8,048,089.
`
`(60) Provisional application No. 60/755,310,filed on Dec.
`30, 2005, provisional application No. 60/764,668,
`filed on Feb. 2, 2006.
`
`(51)
`
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`
`Int. Cl.
`A6IM 1/00
`AGIB 17/3205
`AGIB 17/50
`A61B 17/00
`AGIN 5/06
`AOIB 17/32
`(52) U.S. Cl
`CPC veeeeeceeee AGIB 17/54 (2013.01); AGIB 17/545
`(2013.01); A61B 50/10 (2016.02); A61B 50/13
`(2016.02); A6IM 1/009 (2014.02); A61B
`2017/00199 (2013.01); A6IB 2017/00761
`(2013.01); A61B 2017/320004 (2013.01):
`A61B 2217/005 (2013.01); AGIN 5/0616
`(2013.01)
`
`(56)
`
`References Cited
`U.S. PATENT DOCUMENTS
`
`2,701,559 A
`2,712,823 A
`2,867,214 A
`2,881,763 A
`2,921,585 A
`3,085,573 A
`3,214,869 A
`3,476,112 A
`3,574,239 A
`3,715,838 A
`3,865,352 A *
`
`2/1955 Cooper
`7/1955 Kurtin
`1/1959 Wilson
`4/1959 Robbins
`1/1960 Schumann
`4/1963 Meyeretal.
`11/1965 Stryker
`11/1969 Elstein
`4/1971 Sollerud
`2/1973 Younget al.
`2/1975 Nelson occ BOLF 3/10
`138/42
`
`3,948,265 A
`3,964,212 A
`3,977,084 A
`4,121,388 A
`4,155,721 A
`4,170,821 A
`4,182,329 A
`4,203,431 A
`4,216,233 A
`4,299,219 A
`4,378,804 A
`4,560,373 A
`4,646,480 A
`4,646,482 A
`4,655,743 A
`4,676,749 A
`4,706,676 A
`4,754,756 A
`4,757,814 A
`4,764,362 A
`4,795,421 A
`4,875,287 A
`4,886,078 A
`4,887,994 A
`4,900,316 A
`4,917,086 A
`4,925,450 A
`4,957,747 A
`5,006,004 A
`5,006,339 A
`5,012,797 A
`5,035,089 A
`5,037,431 A
`A
`5,037,432
`
`4/1976 Al Ami
`6/1976 Karden
`8/1976 Sloan
`10/1978 Wilson
`5/1979 Fletcher
`10/1979 Booth
`1/1980 Smith et al.
`5/1980 Aburaetal.
`8/1980 Stein
`11/1981 Norris, Jr.
`4/1983 Cortese
`12/1985 Suginoet al.
`3/1987 Williams
`3/1987 Chitjian
`4/1987 Hyde
`6/1987 Mabille
`11/1987 Peck
`7/1988 Shelanski
`7/988 Wanget al.
`8/1988 Barchas
`1/1989 Blasius, Jr. et al.
`10/1989 Creasy etal.
`12/1989 Shiffman
`12/1989 Bedford
`2/1990 Yamamoto
`4/1990 Feltovich et al.
`5/1990 Imontiet al.
`9/1990 Stiefel
`4/1991 Dirksing et al.
`4/1991 Bargery et al.
`5/1991 Lianget al.
`7/1991 Tillman et al.
`8/1991 Summerset al.
`8/1991 Molinari
`
`5,100,412
`5,100,424
`5,119,839
`5,122,153
`5,207,234
`5,222,956
`5,242,433
`5,254,109
`5,368,581
`5,391,151
`5,417,674
`5,419,772
`5,460,620
`5,470,323
`5,484,427
`5,562,642
`5,611,687
`5,674,235
`5,676,643
`5,676,648
`5,683,971
`5,697,920
`5,707,383
`5,713,785
`5,735,833
`5,759,185
`5,779,519
`5,800,446
`5,807,353
`5,810,842
`5,813,416
`5,817,050
`5,846,215
`5,848,998
`5,861,142
`5,873,881
`5,879,323
`5,882,201
`5,885,260
`5,908,401
`5,919,152
`5,954,730
`5,971,999
`5,980,555
`6,019,749
`6,024,733
`6,027,402
`6,039,745
`6,042,552
`6,080,165
`6,080,166
`6,090,085
`6,120,512
`6,129,701
`6,136,008
`6,139,553
`6,139,554
`6,142,155
`6,149,634
`6,159,226
`6,162,218
`6,162,232
`6,183,451
`6,183,483
`6,193,589
`6,231,593
`6,235,039
`6,238,275
`6,241,739
`6,264,666
`6,277,128
`6,283,978
`6,299,620
`6,306,119
`6,306,147
`6,322,568
`6,368,333
`6,387,103
`6,409,736
`
`3/1992
`3/1992
`6/1992
`6/1992
`5/1993
`6/1993
`9/1993
`10/1993
`11/1994
`2/1995
`5/1995
`5/1995
`10/1995
`11/1995
`1/1996
`10/1996
`3/1997
`10/1997
`10/1997
`10/1997
`11/1997
`12/1997
`1/1998
`2/1998
`4/1998
`6/1998
`7/1998
`9/1998
`9/1998
`9/1998
`9/1998
`10/1998
`12/1998
`12/1998
`1/1999
`2/1999
`3/1999
`3/1999
`3/1999
`6/1999
`7/1999
`9/1999
`10/1999
`11/1999
`2/2000
`2/2000
`2/2000
`3/2000
`3/2000
`6/2000
`6/2000
`7/2000
`9/2000
`10/2000
`10/2000
`10/2000
`10/2000
`11/2000
`11/2000
`12/2000
`12/2000
`12/2000
`2/2001
`2/2001
`2/2001
`5/2001
`5/2001
`5/2001
`6/2001
`7/2001
`8/2001
`9/2001
`10/2001
`10/2001
`10/2001
`11/2001
`4/2002
`5/2002
`6/2002
`
`Rosso
`Jang
`Rudolph
`Harrel
`Rosso
`Waldron
`Smith et al.
`Smith et al.
`Smith et al.
`Wilmot
`Smith et al.
`Teitz et al.
`Smith et al.
`Smith et al.
`Gibbons
`Smith et al.
`Wagner
`Parisi
`Cannetal.
`Henley
`Roseetal.
`Gibbons
`Bays
`Nishio
`Olson
`Grinberg
`Oliver
`Banuchi
`Schmitz
`Di Fiore et al.
`Rudolph
`Klein
`Zygmont
`Marasco,Jr.
`Schick
`McEwenet al.
`Henley
`Salem
`Mehl, Sr. et al.
`Henley
`Zygmont
`Bernabei
`Naldoni
`Barbutet al.
`Fields et al.
`Eggerset al.
`Oliver
`Di Fiore et al.
`Cornier
`DeJacma
`McEwenet al.
`Mehl, Sr. et al.
`Bernabei
`Cimino
`Beckeretal.
`Dotan
`Karkar et al.
`Rudolph
`Bernabei
`Kim
`Elbrecht et al.
`Shadduck
`Mehl, Sr. et al.
`Chang
`Khalaj
`Meserol
`Parkin et al.
`Metcalf et al.
`Waldron
`Coleman et al.
`Muldner oo. 606/133
`Cheskiet al.
`Shadduck
`Weberetal.
`Bernabei etal.
`Bernabei etal.
`Bernabei etal.
`Shadduck
`Bernabei
`
`2
`
`

`

`US 9,550,052 B2
`
`Page 3
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS.
`
`1/2009 Grimesetal.
`7,482,314 B2
`2/2009 Sukhanovetal.
`7,489,989 B2
`3/2009 Sunetal.
`7,507,228 B2
`9/2009 Van Acker
`7,582,067 B2
`10/2009 Zimmeretal.
`7,597,900 B2
`10/2009 Clarot et al.
`7,597,901 B2
`2/2010 Karasiuk
`7,658,742 B2
`3/2010 Shadduck
`7,678,120 B2
`6/2010 Sadowskietal.
`7,744,582 B2
`9/2010 Shadduck
`7,789,886 B2
`11/2010 Hart et al.
`7,837,695 B2
`3/2011 Tavger
`7,901,373 B2
`5/2011 Karasiuk
`7,951,156 B2
`9/2011 Davidet al.
`8,025,669 Bl
`11/2011 Waldron
`RE42,960 E
`11/2011 Ignon etal.
`8,048,089 B2
`11/2011 Shadduck
`8,066,716 B2
`1/2012 Thiebaut et al.
`8,088,085 B2
`3/2012 Karasiuk etal.
`8,128,638 B2
`7/2012 Waldron etal.
`8,221,437 B2
`8/2012 Boone,III et al.
`8,236,008 B2
`10/2012 Hart
`8,277,287 B2
`12/2012 Shadduck
`8,337,513 B2
`1/2013 Ignonetal.
`8,343,116 B2
`8/2014 Ignonetal.
`8,814,836 B2
`6/2015 Ignonetal.
`9,056,193 B2
`9/2001 Eilers
`2001/0023351 Al
`11/2001 Shadduck
`2001/0037118 Al
`2001/0049511 A1* 12/2001 Coleman ........0.... A61H 9/00
`604/290
`
`6/2002 Johnson
`6,410,599 BL
`7/2002 Henley
`RE37,796 E
`7/2002 Johnson
`6,414,032 BL
`7/2002 Johnson
`6,420,431 BL
`7/2002 Baysetal.
`6,423,078 BL
`7/2002 Johnson
`6,423,750 BL
`8/2002 Parkin etal.
`6,432,113 Bl
`8/2002 ROSSO veces 606/131
`6,432,114 BL*
`10/2002 Burres
`6,471,712 B2
`11/2002 Henley et al.
`6,477,410 Bl
`11/2002 Bernabeiet al.
`6,482,212 Bl
`12/2002 Zygmont
`6,488,646 Bl
`12/2002 Zygmont
`6,494,856 BL
`12/2002 Waldron
`6,500,183 Bl
`1/2003 Parkin et al.
`6,503,256 B2
`1/2003 Mercieret al.
`6,511,486 B2
`3/2003 Di Fiore et al.
`6,514,262 BL
`3/2003 _Ignon
`6,527,783 Bl
`3/2003 Bernabei
`6,535,761 B2
`4/2003 Hruska et al.
`6,540,757 BL
`5/2003 Marasco, Jr.
`6,562,013 Bl
`5/2003 Owen
`6,562,050 BL
`5/2003 Ostrow et al.
`6,564,093 BL
`5/2003 Zaias et al.
`6,565,535 B2
`6/2003 Simonetal.
`6,582,442 B2
`7/2003 Garcia
`6,589,218 B2
`2/2002 Shadduck
`2002/0016601 Al
`7/2003 Mallett et al.
`6,592,595 Bl
`4/2002 Cheski
`2002/0041891 Al
`10/2003 Ignon
`6,629,983 Bl
`5/2002 Weberet al.
`2002/0058952 Al
`11/2003 Shadduck
`6,641,591 BL
`8/2002 Burres
`2002/0107527 Al
`11/2003 Zelicksonetal.
`6,645,184 Bl
`9/2002 Citow
`2002/0133110 Al
`11/2003 Rhoades
`6,652,888 B2
`9/2002 Parkin etal.
`2002/0133176 Al
`1/2004 Tavgeretal.
`6,673,081 Bl
`10/2002 Rameyet al.
`2002/0151826 Al
`1/2004 Mallett et al.
`6,673,082 B2
`10/2002 Mallett, Sr. et al.
`2002/0151908 Al
`2/2004 Angelopoulousetal.
`6,685,853 Bl
`12/2002 Hruska
`2002/0188261 Al
`2/2004 Bernabei
`6,687,537 B2
`
`
`6,695,853 B2* 2003/0012415 Al—1/2003 Cossel2/2004 Karasiuk occ: 606/131
`6,735,470 B2
`5/2004 Henley etal.
`2003/0018252 Al*
`1/2003 Duchon .........0.... A61B 6/481
`6,743,211 Bl
`6/2004 Prausnitz et al.
`600/432
`6,743,215 B2
`6/2004 Bernabei
`6,764,493 Bl
`7/2004 Weberet al.
`6,869,611 Bl
`3/2005 Kligman et al.
`6,905,487 B2
`6/2005 Zimmerman
`6,911,031 B2
`6/2005 Muldner
`6,924,649 B2
`8/2005 Knoedgen
`6,926,681 Bl
`8/2005 Rameyetal.
`6,942,649 B2
`9/2005 Ignonetal.
`7,001,355 B2
`2/2006 Nunomuraet al.
`7,004,933 B2
`2/2006 McDaniel
`7,044,938 B2
`5/2006 La Biancoet al.
`7,052,503 B2
`5/2006 Bernabei
`7,069,073 B2
`6/2006 Henleyet al.
`7,070,488 B2
`7/2006 Suissa et al.
`7,083,580 B2
`8/2006 Bernabei
`7,087,063 B2
`8/2006 Carson etal.
`7,094,252 B2
`8/2006 Koop
`7,115,275 B2
`10/2006 Clarotet al.
`7,135,011 B2
`11/2006 Powersetal.
`7,153,311 B2
`12/2006 Chung
`7,197,359 Bl
`3/2007 Tokudomeetal.
`7,198,623 B2
`4/2007 Fischeretal.
`
`6/2007 Chang oo. 606/131
`7,232,444 B2*
`7,241,208 B2
`7/2007 Suissa et al.
`7,276,051 Bl
`10/2007 Henleyetal.
`7,314,326 B2
`1/2008 Rosenberg
`7,316,657 B2
`1/2008 Kleinhenz et al.
`7,318,828 Bl
`1/2008 Revivo
`7,320,691 B2
`1/2008 Pilcher et al.
`7,320,801 B2
`1/2008 Kelly
`7,354,423 B2
`4/2008 Zelicksonetal.
`7,364,565 B2
`4/2008 Freeman
`7,384,405 B2
`6/2008 Rhoades
`7,427,273 B2
`9/2008 Mitsui
`7,458,944 B2
`12/2008 Liste et al.
`7,476,205 B2
`1/2009 Erdmann
`7,A77,938 B2
`1/2009 Sun etal.
`
`2003/0060834 Al
`2003/0093040 Al
`2003/0093089 Al*
`
`2003/0097139 Al
`2003/0167032 Al
`2003/0187462 Al
`2003/0208159 Al
`2003/0212127 Al
`2003/0212415 Al
`2004/0010222 Al
`2004/0010269 Al
`2004/0087972 Al
`2004/0092895 Al
`2004/0092959 Al
`2004/0097967 Al
`2004/0122447 Al
`2004/0143274 Al
`2004/0162565 Al
`2004/0166172 Al
`2004/0219179 Al
`2004/0236291 Al
`2004/0243149 Al
`2004/0254587 Al
`2004/0267285 Al
`2005/0037034 Al
`2005/0038448 Al
`2005/0059940 Al
`2005/0084509 Al
`2005/0148958 Al
`2005/0203111 Al
`2005/0209611 Al
`2005/0283176 Al
`2006/0002960 Al
`2006/0116674 Al*
`2006/0161178 Al
`2006/0189964 Al
`
`3/2003 Muldner
`5/2003 Mikszta et al.
`5/2003 Greenberg ........... A61B 17/545
`606/131
`
`5/2003 Karasiuk
`9/2003 Ignon
`10/2003 Chang
`11/2003 Ignonetal.
`11/2003 Glassman etal.
`11/2003 Karasiuk
`1/2004 Nunomuraet al.
`1/2004 Grimeset al.
`§/2004 Mulhollandet al.
`5/2004 Harmon
`5/2004 Bernaz
`5/2004 Ignon
`6/2004 Harmonetal.
`7/2004 Shadduck
`8/2004 Carson etal.
`8/2004 Rosati et al.
`11/2004 McDaniel
`11/2004 Zelickson etal.
`12/2004 Lee, Jr.
`12/2004 Park
`12/2004 Chang
`2/2005 Rhoades
`2/2005 Chung
`3/2005 Weberet al.
`4/2005 Bernstein
`7/2005 Rucinski
`9/2005 David
`9/2005 Greenberg
`12/2005 Law
`1/2006 Zoeteweij et al.
`6/2006 Goble et al. oe, 606/41
`7/2006 Lee
`8/2006 Anderson
`
`3
`
`

`

`US 9,550,052 B2
`
`Page 4
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`
`2011/0082415 Al
`2012/0022435 Al
`2012/0041338 Al
`2012/0136374 Al
`2013/0018317 Al
`2013/0066336 Al
`2013/0096577 Al
`2013/0102978 Al
`2013/0144280 Al
`2013/0158547 Al
`2014/0343481 Al
`2014/0343574 Al
`2015/0032047 Al
`2015/0230824 Al
`2015/0230825 Al
`2015/0231379 Al
`2015/0265822 Al
`2015/0290442 Al
`2016/0038183 Al
`
`4/2011 Ignon et al.
`1/2012 Ignonet al.
`2/2012 Chickering, III et al.
`5/2012 Karasiuk
`1/2013 Bobroff et al.
`3/2013 Boone,III et al.
`4/2013 Shadduck
`4/2013 Ignon etal.
`6/2013 Eckhouseet al.
`6/2013 David
`11/2014 Ignon
`11/2014 Ignonet al.
`1/2015 Ignonet al.
`8/2015 Shadduck
`8/2015 Shadduck
`8/2015 Ignonet al.
`9/2015 Ignon et al.
`10/2015 Ignonet al.
`2/2016 Ignon et al.
`
`Numomura
`Al
`8/2006
`2006/019 1562
`Al
`La Biancoetal.
`9/2006
`2006/0200099
`Al
`Shadduck
`9/2006
`2006/0200172
`Al
`Shadduck
`9/2006
`2006/0200173
`Al
`9/2006
`2006/02 12029
`Arcusa Villacampaetal.
`Al
`11/2006
`2006/0253125
`Ignon
`Al
`11/2006
`2006/0264893
`Sage, Jr. et al.
`Al
`Hart etal.
`1/2007
`2007/0005078
`Al
`2/2007
`2007/0043382
`Cheney
`Al
`3/2007
`2007/00655 15
`Key
`Al
`Karasiuk
`4/2007
`2007/0088371
`Al
`Rhoades
`5/2007
`2007/0123808
`Al
`Hattendorfet al.
`7/2007
`2007/0154502
`Al
`7/2007
`2007/0156124
`Ignonetal.
`Al
`First et al.
`8/2007
`2007/0178121
`Al
`8/2007
`2007/0198031
`Kellogg
`Al
`Shadduck
`9/2007
`2007/0208353
`Al
`10/2007
`2007/0239173
`Khalaj
`Al
`1/2008
`2008/0027328
`DE 10 2004 015815 Al—11/2005
`
`Klopotek et al.
`Al
`2008/009 1179
`4/2008
`Durkinetal.
`EP
`0 258 901
`9/1987
`Al
`2008/0103563
`5/2008
`Powell
`EP
`0 564 392
`3/1993
`Al
`2008/0119781
`5/2008
`IT
`553 076
`12/1956
`King
`Al
`2008/01329 14
`6/2008
`Bossardet al.
`IT
`118 49 22
`3/1985
`Al
`2008/0139974
`6/2008
`DaSilva
`JP
`1993-088552
`12/1993
`Al
`2008/0154161
`6/2008
`Abbott
`JP
`09-294747
`11/1997
`Al
`2008/0193493
`8/2008
`Rhoades
`JP
`2003-339713
`12/2003
`Al
`2008/0200861
`8/2008
`Shalev et al.
`JP
`2006-503627
`2/2006
`Al
`2008/0208 146
`8/2008
`Brandweinetal.
`JP
`2006-204767
`10/2006
`Al
`Xu
`2008/02 14987
`9/2008
`KR
`20-0280320
`7/2002
`Al
`2008/02 15068
`9/2008
`Hart etal.
`WO
`WO 00/15300
`3/2000
`Al
`2008/022 1548
`9/2008
`WO
`WO 01/93931
`12/2001
`Danenberg etal.
`Al
`2008/0243039
`10/2008
`Rhoades
`WO
`WO 03/073917
`9/2003
`Al
`2008/0287864
`11/2008
`WO
`WO 2004/037098
`5/2004
`Rosenberg
`Al
`2008/0300529
`12/2008
`Reinstein
`WO
`WO 2005/070313
`8/2005
`Al
`2008/0300552
`12/2008
`Cichocki etal.
`WO
`WO 2006/01873 1
`2/2006
`Al
`2009/0048557
`2/2009
`Yeshurun etal.
`WO
`WO 2007/114904
`10/2007
`Al
`2009/0053390
`2/2009
`Sakouet al.
`WO
`WO 2012/145667
`10/2012
`Al
`2009/0062815
`3/2009
`Karasiuk et al.
`Al
`2009/009909 1
`4/2009
`Hantash
`Al
`2009/0099093
`4/2009
`Hantash
`Al
`2009/0124985
`5/2009
`Hasenoehrlet al.
`Al
`Wu
`2009/0138026
`5/2009
`2009/0177171
`7/2009
`Ignonetal.
`2009/0192442
`7/2009
`Ignonetal.
`2009/0222023
`9/2009
`Boone,III et al.
`2010/0045427
`2/2010
`Boone,III et al.
`2010/0049177
`2/2010
`Boone,III et al.
`2010/00492 10
`2/2010
`Boone,III et al.
`2010/0217357
`8/2010
`DaSilva
`Hart
`2011/0054490
`3/2011
`2011/0066162
`3/2011
`Cohen
`
`Ditre et al., Effect of a-hydroxy acids on photoaged skin: A pilot
`clinical, histologic, and ultrastructural study, Journal of American
`Academy of Dermatology, Feb. 1996, vol. 34, No. 2, Part 1, pp.
`187-195.
`Harris et al., Combining Manual Dermasanding with Low Stregnth
`Trichloroacetic Acid to Improve Antinically Injured Skin, The Jour-
`nal of Dermatologic Surgery and Oncology, Jul. 1994, vol. 20, No.
`7, pp. 436-442.
`
`FOREIGN PATENT DOCUMENTS
`
`OTHER PUBLICATIONS
`
`* cited by examiner
`
`4
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 1 of 25
`
`US 9,550,052 B2
`
`©
`
`
`
`
`
`
`
`
`
`—Wiye\VFla
`
`V/»/
`[RY
`
`>
`
`
`
`@
`
`~NY
`
`©
`
`
`
`
`
`5
`
`
`
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 2 of 25
`
`US 9,550,052 B2 VIG.24
`
`6
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 3 of 25
`
`US 9,550,052 B2
`
`
`
`
`
`\,
`
`PIG.2B
`
`
`
`
`
`
`7
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 4 of 25
`
`US 9,550,052 B2
`
`
`
`
`
`
`
`
`
`
`
`
`weLLLZITEErgENS
`SNA/9DserroORTaEepeVisITN
`
`
`\UEQN
`
`[itl
`
`ee¢
`
`TERA?NOS
`
`
`
`SoS
`
`8
`
`
`
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`US 9,550,052 B2
`
`Sheet 5 of 25
`
`PIG.4
`
`9
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 6 of 25
`
`US 9,550,052 B2
`
`
`
`10
`
`

`

`U.S. Patent
`
`Jan, 24, 2017
`
`Sheet 7 of 25
`
`US 9,550,052 B2
`
`
`
` |WN)
`
`G9
`
`11
`
`
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 8 of 25
`
`US 9,550,052 B2
`
`
`QS
`AIN
`
`174
`
`
`
`
`
`
`
`
`WyISX
`
`
`
`
`on
`
`
`66.
`
`
`12
`
`

`

`U.S. Patent
`
`Jan, 24, 2017
`
`Sheet 9 of 25
`
`US 9,550,052 B2
`
`
`
`64
` ISSY
`
`777611499
`
`
`13
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 10 of 25
`
`US 9,550,052 B2
`
`66.
`
`KSEE
`
`
`64
`HUGHC
`
`14
`
`

`

`U.S. Patent
`
`US 9,550,052 B2
`
`Jan. 24, 2017
`
`Sheet 11 of 25
`
`
`
`15
`
`

`

`U.S. Patent
`
`Jan, 24, 2017
`
`Sheet 12 of 25
`
`US 9,550,052 B2
`
`GZ|RES
`
`REL
`
`EGC|LGC
`
`yw
`
`£GE
`
`WD!MD
`
`LITYB
`
`LL)YDB
`
`LGC
`
`REL
`
`LGE£GC
`
`SGT
` FEL
`LGC
`
`LGE
`
`16
`
`BDMB
`
`QD!YB
`
`16
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 13 of 25
`
`US 9,550,052 B2
`
`PIG.L?
`
`17
`
`

`

`U.S. Patent
`
`Jan, 24, 2017
`
`Sheet 14 of 25
`
`US 9,550,052 B2
`
`n~
`
`3g
`
`ne
`
`O27
`
`
`
`18
`
`
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`US 9,550,052 B2
`
`Sheet 15 of 25
`
`78
`
`
`
`
`
`
`
`lg: IB
`
`19
`
`19
`
`

`

`U.S. Patent
`
`Jan, 24, 2017
`
`Sheet 16 of 25
`
`US 9,550,052 B2
`
`Y%x
`
`
`
`
`
`
`
`
`20
`
`20
`
`
`

`

`U.S. Patent
`
`Jan, 24, 2017
`
`Sheet 17 of 25
`
`US 9,550,052 B2
`
`
`
`
`
`
`
`
`21
`
`21
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 18 of 25
`
`US 9,550,052 B2
`
`
`
`
`
`
`
`
`
`22
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 19 of 25
`
`US 9,550,052 B2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` FIG.LIB
`
`
`
`
`
`lia
`
`
`
`62
`O4
`
`
`
`
`
`
`Ld
`
`23
`
`23
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 20 of 25
`
`US 9,550,052 B2
`
`
`
`
`
`
`
`
`
`
`Laps
`
`
`
`BES,fp
`
`mg GEpr
`
`
`
`
`
`
`
`
`Lge LIC
`
`24
`
`24
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 21 of 25
`
`US 9,550,052 B2
`
` 2g
`
`[1][EEEERGy
`ALT,iGSEEN
`
`
`ANNE
`
`
`m
`
`
`Beare)
`
`
`
`
`L1G. LID
`
`
`
`/F
`
`
`
`25
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 22 of 25
`
`US 9,550,052 B2
`
`UV,
`YAMeb.veSH4
`afeAGSAN
`
`
`S17
`
`FIG? LIE
`
`26
`
`

`

`U.S. Patent
`
`Jan, 24, 2017
`
`Sheet 23 of 25
`
`US 9,550,052 B2
`
`
`
`VIG. 16
`
`IO
`
`27
`
`27
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 24 of 25
`
`US 9,550,052 B2
`
`
`
`66
`
`
`
`
`
`
`
`
`
`
`\
`
`577
`
`28
`
`

`

`U.S. Patent
`
`Jan. 24, 2017
`
`Sheet 25 of 25
`
`US 9,550,052 B2
`
`J62
`
`L1G.LI
`
`66
`
`
`
`
`J60
`
`577
`
`
`
`29
`
`29
`
`

`

`US 9,550,052 B2
`
`2
`pulled towards the handpiece whereit is treated with the grit
`stream, allowing for simultaneous local treatment and suc-
`tion.
`Microdermabrasion removes moisture from the skin, so
`the procedure is always followed by the application of
`moisturizing creams. However, similar to topical application
`of moisturizing creams prior to microdermabrasion,
`the
`moisturizing elements only work as deep as the active
`ingredients can passively migrate through the remaining
`epidermis.
`
`10
`
`SUMMARY OF THE INVENTION
`
`1
`CONSOLE SYSTEM FOR THE TREATMENT
`OF SKIN
`
`CROSS-REFERENCE TO RELATED
`APPLICATIONS
`
`This is a continuation of U.S. patent application Ser. No.
`13/267,554, filed Oct. 6, 2011, which is a continuation of
`USS. patent application Ser. No. 11/392,348, filed Mar. 29,
`2006, which claims the benefit of U.S. Provisional Appli-
`cation No. 60/755,310, filed Dec. 30, 2005 and U.S. Provi-
`sional Application No. 60/764,668, filed Feb. 2, 2006, the
`entireties of all of the aforementioned applications are
`hereby incorporated by reference herein.
`
`BACKGROUND
`
`Field
`
`to the field of skin
`The invention relates in general
`treatment, and morespecifically to apparatuses and methods
`for treating a person’s skin.
`Description of the Related Art
`Abrasion of the outer layer or epidermis of the skin is
`desirable to smooth or blend scars, blemishes, or other skin
`conditions that may be caused by, for example, acne, sun
`exposure, and aging. Standard techniques used to abrade the
`skin have generally been separated into twofields referred to
`as dermabrasion and microdermabrasion. Both techniques
`remove portions of the epidermis called the stratum cor-
`neum, which the body interprets as a mild injury. The body
`then replaces the lost skin cells, resulting in a new outer
`layer of skin. Additionally, despite the mild edema and
`erythemaassociated with the procedures, the skin looks and
`feels smoother because of the new outer layer of skin.
`Dermabrasion refers to a procedure in which the surface
`of the skin is removed due to mechanical rubbing by a
`handpiece with an abrasive element that is often in the form
`of a burr, wheel, or disc. This process tends to be painful and
`messy. In fact, the procedure is sometimes painful enough to
`require a local anesthetic. Dermabrasion leaves the skin red
`and raw-looking. The removed skin can take several months
`to regrow and heal. Recent efforts have led to the use of
`lasers instead of abrasive elements, which have resulted in
`less bleeding, but the pain and mess remains.
`Efforts have been made to decrease the mess caused by
`the process waste, such as removed skin and blood, by
`adding a suction element. As the process waste is drawn into
`the suction opening, skin that has not been removed is also
`pulled against the grit surrounding the suction opening, so
`the procedure remains fairly messy due to the abrasion that
`takes place outside of the handpiece by the grit.
`Microdermabrasion refers generally to a procedure in
`which the surface of the skin is removed due to mechanical
`
`rubbing by a handpiece emitting a stream of sandorgrit. For
`example, a handpiece can be used to direct an air flow
`containing tiny crystals of aluminum oxide, sodium chlo-
`ride, or sodium bicarbonate. The momentum ofthe grit tends
`to wear away twoto three cell layers of the skin with each
`pass of the handpiece. Alternatively, new “crystal-free”
`microdermabrasion techniques utilize a diamond-tipped
`handpiece without a stream ofgrit.
`Efforts to add a suction element have been more success-
`ful in microdermabrasion than in dermabrasion because the
`
`handpiece applying the stream ofgrit is more controllable to
`a localized area. That is, as the removed skin is drawn into
`the suction opening, skin that has not been removed is also
`
`15
`
`20
`
`25
`
`30
`
`35
`
`In some embodiments, an apparatus for treating skin has
`aconsole with a user input device and a handpiece assembly.
`The handpiece assembly is configured to treat skin. A fluid
`line provides fluid communication between the console and
`the handpiece assembly. A manifold system is coupled to the
`console and controlled by the user input device, such as a
`computer, touchscreen, keyboard, and the like. The manifold
`system is configured to hold releasably a plurality of fluid
`sources and deliver fluid from at least one of the plurality of
`fluid sources to the handpiece assembly.
`In some embodiments, a tip comprising a skirt portion is
`configured to couple to a handpiece for treating a target area
`on a patient’s skin. A central body portion is coupled to the
`skirt portion. A first passage extends through the central
`body portion and is configured to receive a fluid from the
`handpiece. At
`least one second passageway extending
`through the central body portion and is configured to convey
`the fluid back into the handpiece. An inner member extends
`in a generally spiral fashion across at least a portion of a
`distal face of the central body portion. The inner member
`defines a channel betweenthe first passage and the at least
`one second passage. Whenthetip is place against the skin,
`a chamber can be formed by the channel and the person’s
`skin.
`In some embodiments, a methodoftreating a target region
`on a patient’s skin comprises providing a tip includinga first
`aperture and at least one second aperture. At least one inner
`memberon the surface of the tip defines at least one channel
`between the first aperture and the at
`least one second
`aperture. An outer memberis disposed on the surface of the
`tip. The outer member engages the target with the tip. A
`treatment fluid flows distally through the first aperture
`region and through the at least one channel. The treatment
`fluid flows proximally through the at
`least one second
`aperture.
`In some embodiments, a tip comprises a skirt portion
`configured to couple to a handpiece for treating a target on
`a patient’s skin. A central body portion is coupled to the skirt
`portion and includes a mounting region substantially oppo-
`site the skirt portion. The mounting region configured to
`receive a pad for treating the skin. A first aperture extends
`through the skirt portion and the central body portion and
`configured to receive a fluid from the handpiece. At least one
`second aperture extending through the skirt portion and the
`central body portion and configured to convey the fluid back
`into the handpiece.
`In some embodiments, a methodoftreating a target region
`of a patient comprises providing a tip including a first
`aperture, at
`least one second aperture, and a distal end
`configured to receive a pad. In somevariations, thefirst pad
`is attached to the distal end. The tip is engaged with the
`target region.
`In some embodiments, a manifold system comprises a
`body portion configured to receive releasably at least two
`30
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`30
`
`

`

`US 9,550,052 B2
`
`3
`bottles. The manifold is configured so that it can be coupled
`to a console. The console includes a handpiece for treating
`skin. At least one elongate member is in communication
`with a pumpand configuredto extract a fluid from one of the
`at least two bottles. At least one switch is configured to
`permit or inhibit a flow of the fluid from oneof the at least
`two bottles through the pump.
`In some variations,
`the
`elongate memberis dimensioned tofit within one ofat least
`two bottles to draw fluid out of the bottle.
`In some embodiments, a methodoftreating a target region
`on a patient’s skin comprises engaging a tip with the
`patient’s skin such that an effective amount of skin is
`removed by the tip. In somevariations, the tip is a dry tip.
`After removing an effective amountof skin, anothertip (e.g.,
`a wet tip) engages the patient’s skin such that an effective
`amount of skin is removed by the tip. In some variations,
`acid is delivered out of the wettip to facilitate skin removal.
`In some variations, the wet tip includes a first aperture, at
`least one second aperture, at least one inner member on the
`surface of the tip defining at least one channel between the
`first aperture and the at least one second aperture, and an
`outer memberon the surface of the tip. In some variations,
`treatment fluid flows outwardly along the channel. In some
`variations, treatment fluid flows inwardly along the channel.
`In some variations, the wet tip comprises an abrasive pad.
`In some embodiments, a methodoftreating a target region
`on a patient’s skin comprises engaginga first skin treatment
`tip with the patient’s skin. A first material is delivered out of
`the first skin treatmenttip to a target region. A second skin
`treatment tip engages the target region while the first mate-
`rial effectively facilitates exfoliation with the second skin
`treatmenttip. In somevariations,the first material comprises
`an acid, hydrator, and combination thereof. In some varia-
`tions, the first skin treatmenttip is configured to remove skin
`at a different rate than the second skin treatmenttip. In some
`variations, the first skin treatment tip is configured to exfo-
`liate at a higher rate than the second skin treatment tip. In
`some variations, material
`is delivered out of the second
`treatment tip to the target region of the patient’s skin.
`The apparatus for treating skin can dispense treatment
`material that is held in containers, such as bottles, bags,
`pouches, or other suitable structures for holding and storing
`material. These containers can be non-refillable orrefillable.
`
`The treatment material can be delivered by gravity feed,
`pumps, or suction devices. The manifold system can be used
`to control fluid flow from a plurality of containers to one or
`more handpieces.
`
`BRIEF DESCRIPTION OF THE DRAWINGS
`
`Having thus summarized the general nature of the inven-
`tion, certain preferred embodiments and modifications
`thereof will become apparent to those skilled in the art from
`the detailed description herein having reference to the fig-
`ures that follow.
`FIG. 1 is a perspective view of one embodimentof a skin
`treatment system.
`FIG. 2A is a perspective view of one embodiment of a
`handpiece assembly for use with the skin treatment system
`of FIG. 1.
`FIG. 2B is a side elevational view of the handpiece
`assembly of FIG. 2A.
`FIG. 3 is a longitudinal cross-sectional view of the
`handpiece assembly of FIG. 2B. The handpiece assembly is
`engaging a person’s skin.
`FIG.4 is a perspective view of another embodimentof a
`handpiece assembly.
`
`4
`FIG. 5A is a perspective view of one embodimentofa tip
`that can be coupled to a main body of a handpiece assembly
`to treat a person’s skin.
`FIG. 5B is a top elevational view of the tip of FIG. 5A.
`FIG. 5C illustrates a bottom elevational view ofthetip of
`FIG. 5A.
`
`FIG. 5D is a cross-sectional view of the tip of FIG. 5B
`taken along the line 5D-5D.
`FIG. 6A is a perspective view of a tip in accordance with
`another embodiment.
`
`FIG. 6B is a top elevational view of the tip of FIG. 6A.
`FIG.6C is a bottom elevational view ofthe tip of FIG. 6A.
`FIG. 6D is a cross-sectional view of the tip of FIG. 6B
`taken along the line 6D-6D.
`FIG.7A is a perspective view of a tip in accordance with
`another embodiment.
`
`FIG. 7B is a top elevational view of the tip of FIG. 7A.
`FIG.7C is a bottom elevational view of the tip of FIG. 7A.
`FIG. 7D is a cross-sectional view of the tip of FIG. 7B
`taken along the line 7D-7D.
`FIG.8A is a perspective view of yet another embodiment
`of a tip for treating a person’s skin.
`FIG. 8B is a top elevational view of the tip of FIG. 8A.
`FIG.8C is a bottom elevational view ofthe tip of FIG. 8A.
`FIG. 8D is a cross-sectional view of the tip of FIG. 8B
`taken along the line 8D-8D.
`FIG.9A is a perspective view ofstill another embodiment
`of a tip that can be coupled to a main body of a handpiece
`assembly.
`FIG. 9B is a top elevational view of the tip of FIG. 9A.
`FIG.9C is a bottom elevational view ofthe tip of FIG. 9A.
`FIG. 9D is a cross-sectional view of the tip of FIG. 9B
`taken along the line 9D-9D.
`FIG. 10A is a perspective view of another embodiment of
`a tip for treating a person’s skin.
`FIG. 10B is top elevational view ofthe tip of FIG. 10A.
`FIG. 10C is bottom elevational view of the tip of FIG.
`10A.
`
`FIG. 10D is a cross-sectional view ofthe tip of FIG. 10B
`taken along the line 10D-10D.
`FIG. 10Eis a perspective exploded view ofthe tip of FIG.
`10A, wherein a pad is spaced from a tip main body.
`FIGS. 11A-11E are cross-sectional views of inner mem-
`bers that can be used to exfoliate skin.
`
`FIG. 12 is a perspective view of a bottle for use with the
`skin treatment system of FIG.1.
`FIG. 13A is a cross-sectional view of one embodiment of
`a bottle spaced from an insertion tip assembly.
`FIG. 13B is a cross-sectional view of the bottle of FIG.
`
`12A coupled with the insertion tip assembly.
`FIG. 14A is a cross-sectional view of a closure and a
`bottle.
`FIG. 14B is a cross-sectional view of the closure and
`bottle of FIG. 14A when assembled.
`FIG. 15A is a perspective view of one embodiment of a
`manifold system holding a plurality of bottles.
`FIG. 15B is a cross-sectional view of the manifold system
`of FIG. 15A taken along the line 15B-15B of FIG. 15A.
`FIG. 15C is a cross-sectional view of the manifold system
`of FIG. 15A taken along the line 15C-15C of FIG. 15A.
`FIG. 15D is a cross-sectional view of the manifold system
`of FIG. 15C wherein the bottle has been removed.
`FIG. 15E is a cross-sectional elevational view of the
`
`manifold system.
`FIG. 16 is a perspective view of another embodiment of
`a skin treatment system.
`
`25
`
`35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`31
`
`31
`
`

`

`US 9,550,052 B2
`
`5
`FIG.17 is a cross-sectional view ofa fluid line of the skin
`
`treatment system of FIG. 16 taken along the line 17-17.
`FIG. 18is a side elevational view of a handpiece assembly
`with a removable cartridge.
`FIG. 19 is a side elevational view of the handpiece
`assembly and removable cartridge of FIG. 18, the cartridge
`is shown removed from the handpiece assembly.
`
`DETAILED DESCRIPTION OF THE
`PREFERRED EMBODIMENT
`
`10
`
`6
`In the illustrated embodiment, the console 12 comprises
`four casters 33 to allow for easy movement, for example,
`from one treatment room to another treatment room.In such
`
`an embodiment, the console 12 can be conveniently rolled
`on a support surface. Other meansoftransportation can also
`be employed or the console 12 can be stationary. In some
`embodiments,
`the console 12 is portable for convenient
`transport.
`The illustrated containers 26 of FIG. 1 are preferably
`releasably coupled to the manifold system 24. The manifold
`system 24 can deliver treatment material from the containers
`26 to the line 20 as mentioned above. In certain embodi-
`
`FIG.1 illustrates a skin treatment system 10 that can be
`used to perform one or more treatments on a person’s skin.
`Theillustrated skin treatment system 10 includes a console
`12 and a handpiece assembly 18 connected to the console 12
`via a line 20. A manifold system 24 can control the f